These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 11175846)
1. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Surolia N; Surolia A Nat Med; 2001 Feb; 7(2):167-73. PubMed ID: 11175846 [TBL] [Abstract][Full Text] [Related]
2. Structural basis for triclosan and NAD binding to enoyl-ACP reductase of Plasmodium falciparum. Suguna K; Surolia A; Surolia N Biochem Biophys Res Commun; 2001 Apr; 283(1):224-8. PubMed ID: 11322792 [TBL] [Abstract][Full Text] [Related]
3. Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors. Kapoor M; Dar MJ; Surolia A; Surolia N Biochem Biophys Res Commun; 2001 Dec; 289(4):832-7. PubMed ID: 11735121 [TBL] [Abstract][Full Text] [Related]
4. Paradigm shifts in malaria parasite biochemistry and anti-malarial chemotherapy. Surolia N; RamachandraRao SP; Surolia A Bioessays; 2002 Feb; 24(2):192-6. PubMed ID: 11835284 [TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the triclosan-binding region of enoyl-ACP (acyl-carrier protein) reductase from Plasmodium falciparum. Kapoor M; Gopalakrishnapai J; Surolia N; Surolia A Biochem J; 2004 Aug; 381(Pt 3):735-41. PubMed ID: 15139852 [TBL] [Abstract][Full Text] [Related]
6. New agents to combat malaria. Beeson JG; Winstanley PA; McFadden GI; Brown GV Nat Med; 2001 Feb; 7(2):149-50. PubMed ID: 11175835 [No Abstract] [Full Text] [Related]
7. Synthesis and biological activity of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 2: 2'-substituted triclosan derivatives. Freundlich JS; Yu M; Lucumi E; Kuo M; Tsai HC; Valderramos JC; Karagyozov L; Jacobs WR; Schiehser GA; Fidock DA; Jacobus DP; Sacchettini JC Bioorg Med Chem Lett; 2006 Apr; 16(8):2163-9. PubMed ID: 16466916 [TBL] [Abstract][Full Text] [Related]
8. Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase. Kumar G; Parasuraman P; Sharma SK; Banerjee T; Karmodiya K; Surolia N; Surolia A J Med Chem; 2007 May; 50(11):2665-75. PubMed ID: 17477517 [TBL] [Abstract][Full Text] [Related]
9. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors. Shah P; Siddiqi MI SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586 [TBL] [Abstract][Full Text] [Related]
11. Design, development, synthesis, and docking analysis of 2'-substituted triclosan analogs as inhibitors for Plasmodium falciparum enoyl-ACP reductase. Kapoor N; Banerjee T; Babu P; Maity K; Surolia N; Surolia A IUBMB Life; 2009 Nov; 61(11):1083-91. PubMed ID: 19859979 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4'-substituted triclosan derivatives. Freundlich JS; Anderson JW; Sarantakis D; Shieh HM; Yu M; Valderramos JC; Lucumi E; Kuo M; Jacobs WR; Fidock DA; Schiehser GA; Jacobus DP; Sacchettini JC Bioorg Med Chem Lett; 2005 Dec; 15(23):5247-52. PubMed ID: 16198563 [TBL] [Abstract][Full Text] [Related]
13. Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I. McLeod R; Muench SP; Rafferty JB; Kyle DE; Mui EJ; Kirisits MJ; Mack DG; Roberts CW; Samuel BU; Lyons RE; Dorris M; Milhous WK; Rice DW Int J Parasitol; 2001 Feb; 31(2):109-13. PubMed ID: 11239932 [TBL] [Abstract][Full Text] [Related]
14. Prioritization of active antimalarials using structural interaction profile of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR)-triclosan derivatives. Kumar SP; George LB; Jasrai YT; Pandya HA SAR QSAR Environ Res; 2015; 26(1):61-77. PubMed ID: 25567142 [TBL] [Abstract][Full Text] [Related]
15. Exploring the interaction energies for the binding of hydroxydiphenyl ethers to enoyl-acyl carrier protein reductases. Muralidharan J; Suguna K; Surolia A; Surolia N J Biomol Struct Dyn; 2003 Feb; 20(4):589-94. PubMed ID: 12529157 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of antiprotozoal and plasmodial enoyl-ACP reductase inhibition potential of turkish medicinal plants. Tasdemir D; Brun R; Perozzo R; Dönmez AA Phytother Res; 2005 Feb; 19(2):162-6. PubMed ID: 15852483 [TBL] [Abstract][Full Text] [Related]
17. Enoyl-ACP reductase (FabI) of Haemophilus influenzae: steady-state kinetic mechanism and inhibition by triclosan and hexachlorophene. Marcinkeviciene J; Jiang W; Kopcho LM; Locke G; Luo Y; Copeland RA Arch Biochem Biophys; 2001 Jun; 390(1):101-8. PubMed ID: 11368521 [TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin gallate is a slow-tight binding inhibitor of enoyl-ACP reductase from Plasmodium falciparum. Banerjee T; Sharma SK; Surolia N; Surolia A Biochem Biophys Res Commun; 2008 Dec; 377(4):1238-42. PubMed ID: 18992222 [TBL] [Abstract][Full Text] [Related]
19. Slow-tight-binding inhibition of enoyl-acyl carrier protein reductase from Plasmodium falciparum by triclosan. Kapoor M; Reddy CC; Krishnasastry MV; Surolia N; Surolia A Biochem J; 2004 Aug; 381(Pt 3):719-24. PubMed ID: 15086316 [TBL] [Abstract][Full Text] [Related]
20. Design and in silico screening of combinatorial library of antimalarial analogs of triclosan inhibiting Plasmodium falciparum enoyl-acyl carrier protein reductase. Frecer V; Megnassan E; Miertus S Eur J Med Chem; 2009 Jul; 44(7):3009-19. PubMed ID: 19217192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]